GRI Bio (GRI) Shares Outstanding (Diluted) (2020 - 2026)
GRI Bio (GRI) reported Shares Outstanding (Diluted) of 1.8 million for Q2 2026, down 18.1% from 2.21 million a year earlier but up 45.4% from the prior quarter.
Powered by 
Analysis
GRI Bio (GRI) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
For FY2025, GRI Bio posted Shares Outstanding (Diluted) of 98,162, down 46.4% from FY2024.
- Shares Outstanding (Diluted) has a five-year compound annual growth rate of 102.1% (FY2020 to FY2025).
- By year, Shares Outstanding (Diluted) came in at 183,278 in FY2024, 2,088 in FY2023 (-68.2%), 6,556 in FY2022 (+55.1%) and 4,228 in FY2021 (+45.1%).
- Five-year quarterly Shares Outstanding (Diluted) spans a low of 290.00 in Q1 2023 and a high of 2.62 million in Q3 2025.
- The high point for year-over-year Shares Outstanding (Diluted) in five years was Q1 2026 (growth of 136.2%); the low point was Q1 2023 (a decline of 93.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 1.24 million (Q1 2026), 98,162 (Q4 2025) and 2.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 5.70 Bn |
| 10 | GRI Bio | 3.54 Mn | 3.54 Mn | - | 1.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.80 Mn |
| Mar 31, 2026 | 1.24 Mn |
| Dec 31, 2025 | 98,162.00 |
| Sep 30, 2025 | 2.62 Mn |
| Jun 30, 2025 | 2.21 Mn |
| Mar 31, 2025 | 525,447.00 |
| Dec 31, 2024 | 183,278.00 |
| Sep 30, 2024 | 185,917.00 |
| Jun 30, 2024 | 26,924.00 |
| Mar 31, 2024 | 18,674.00 |
| Dec 31, 2023 | 2,088.00 |
| Sep 30, 2023 | 2,666.00 |
| Jun 30, 2023 | 1,563.00 |
| Mar 31, 2023 | 290.00 |
| Dec 31, 2022 | 6,556.00 |
| Sep 30, 2022 | 7,824.00 |
| Jun 30, 2022 | 5,612.00 |
| Mar 31, 2022 | 4,404.00 |
| Dec 31, 2021 | 4,228.00 |
| Sep 30, 2021 | 4,404.00 |
API Access
GRI Bio Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=GRI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "GRI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=GRI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();